Valuation: Gland Pharma Limited

Market Cap 392B 4.07B 3.58B 3.33B 3.05B 5.73B 5.82B 39.49B 15.43B 193B 15.28B 14.95B 666B P/E 2026
27.2x
P/E 2027 * 31.5x
Enterprise Value 363B 3.77B 3.31B 3.08B 2.83B 5.31B 5.39B 36.56B 14.28B 178B 14.15B 13.85B 617B EV / Sales 2026
3.86x
EV / Sales 2027 * 4.82x
Free-Float
48.23%
Yield 2026
1.18%
Yield 2027 * 0.82%
1 day+0.09%
1 week-2.83%
Current month-4.62%
1 month+2.30%
3 months+38.89%
6 months+41.44%
Current year+38.20%
1 week 2,351.1
Extreme 2351.1
2,497.9
1 month 2,299.2
Extreme 2299.2
2,573.5
Current year 1,573.6
Extreme 1573.6
2,573.5
1 year 1,573.6
Extreme 1573.6
2,573.5
3 years 1,190
Extreme 1190
2,573.5
5 years 861
Extreme 861
4,350
10 years 861
Extreme 861
4,350
Manager TitleAgeSince
Director of Finance/CFO - 2019-09-29
Chief Operating Officer - 2026-04-05
Chief Tech/Sci/R&D Officer - 2026-02-17
Director TitleAgeSince
Chairman 57 2024-06-09
Director/Board Member 71 2018-02-06
Director/Board Member 69 2021-05-16
Date Insider Type Main position Quantity % Market Cap.
2/26/25 Buy 2,800 0.0017%
6/28/24 Sell 1,400 0.0008%
6/28/24 Sell 1,950 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%-2.83%+17.92%+92.02% 4.07B
+0.86%+1.43%+48.50%+160.39% 1,067B
+1.59%+4.09%+55.34%+53.96% 635B
+0.95%+1.91%+35.91%+81.14% 458B
+1.60%+6.25%+33.95%+29.84% 347B
-0.60%+1.52%+35.68%+39.76% 295B
-0.14%+0.60%+16.17%+17.53% 262B
+0.09%-2.82%-28.29%-41.71% 216B
+1.22%+2.66%+21.87%+59.73% 203B
-1.18%-3.70%+14.23%+66.51% 161B
Average +0.34%+0.91%+25.13%+55.92% 364.71B
Weighted average by Cap. +0.55%+1.95%+35.79%+77.69%

Financials

2026 2027 *
Net sales 63.44B 659M 579M 538M 494M 928M 942M 6.39B 2.5B 31.19B 2.47B 2.42B 108B 73.22B 760M 668M 621M 570M 1.07B 1.09B 7.37B 2.88B 36B 2.85B 2.79B 124B
Net income 9.36B 97.2M 85.37M 79.39M 72.85M 137M 139M 943M 368M 4.6B 365M 357M 15.91B 12.48B 130M 114M 106M 97.1M 182M 185M 1.26B 491M 6.13B 486M 476M 21.21B
Net Debt -29.08B -302M -265M -247M -226M -425M -432M -2.93B -1.14B -14.3B -1.13B -1.11B -49.44B -39.1B -406M -357M -332M -304M -572M -581M -3.94B -1.54B -19.22B -1.52B -1.49B -66.47B
Logo Gland Pharma Limited
Gland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, New Chemical Entities (NCE)-1s, First-to-File products, and 505(b)(2) filings. The Company manufactures a range of dosage formulations, including solutions, suspensions, and lyophilized products. Its product portfolio includes delivery methods such as pre-filled syringes, vials, ampoules, bags, and dry powder injections. It also produces generic injectables in liquid, lyophilized, suspension, and pre-filled syringe forms. Its molecules include Enoxaparin Sodium, Cisplatin, Lacosamide, Rocuronium Bromide, Zoledronic Acid, Vancomycin, and others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynecological, Hormones, and others. The Company functions primarily on a business-to-business model. Its subsidiary is Gland Pharma International Pte. Ltd.
Employees
4,351
Date Price Change Volume
26-07-24 ₹2,379.80 +0.09% 156,545
26-07-23 ₹2,377.70 -2.52% 197,918
26-07-22 ₹2,439.10 -1.74% 671,215
26-07-21 ₹2,482.40 +0.95% 210,888
26-07-20 ₹2,459.10 +0.41% 324,971
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
2,379.80INR
Average target price
2,325.29INR
Spread / Average Target
-2.29%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GLAND Stock